| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 34.25▼ | 34.13▲ | 34.31▼ | 35.39▼ | 37.99▼ |
| MA10 | 34.18▼ | 34.63▼ | 34.81▼ | 37.59▼ | 36.16▼ |
| MA20 | 34.70▼ | 35.24▼ | 35.58▼ | 38.37▼ | 34.29▼ |
| MA50 | 35.14▼ | 36.33▼ | 37.81▼ | 35.66▼ | 30.11▲ |
| MA100 | 35.70▼ | 38.62▼ | 38.72▼ | 34.03▲ | 25.66▲ |
| MA200 | 38.13▼ | 38.04▼ | 36.85▼ | 30.64▲ | 23.79▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.028▼ | -0.052▼ | -0.044▼ | -0.858▼ | -0.024▼ |
| RSI | 37.297▼ | 36.672▼ | 33.588▼ | 39.419▼ | 51.381▲ |
| STOCH | 33.839 | 13.987▼ | 14.509▼ | 11.121▼ | 70.566 |
| WILL %R | -78.840▼ | -82.967▼ | -90.549▼ | -96.089▼ | -62.207 |
| CCI | -48.847 | -100.102▼ | -117.317▼ | -121.120▼ | -28.917 |
|
Monday, January 26, 2026 04:02 PM
To ensure that no patient is left behind in receiving this potentially life-saving therapy, Mesoblast has established a patient access hub termed MyMesoblast™, where Ryoncil ® is available for ...
|
|
Tuesday, January 20, 2026 09:33 AM
Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and lower opioid use in a late-stage trial.
|
|
Monday, January 19, 2026 12:25 AM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/01/26 | 34.15 | 34.15 | 34.15 | 34.15 | 6,131 |
| 26/01/26 | 35.60 | 35.94 | 33.815 | 34.10 | 82,165 |
| 23/01/26 | 36.35 | 37.12 | 35.11 | 35.50 | 29,420 |
| 22/01/26 | 37.33 | 37.505 | 36.1801 | 36.52 | 20,580 |
| 21/01/26 | 36.05 | 37.3301 | 35.00 | 36.68 | 92,272 |
| 20/01/26 | 39.20 | 39.21 | 35.00 | 35.69 | 140,880 |
| 16/01/26 | 40.44 | 41.96 | 40.25 | 40.96 | 22,864 |
| 15/01/26 | 41.32 | 42.00 | 40.50 | 40.64 | 37,292 |
| 14/01/26 | 41.03 | 42.38 | 40.44 | 41.07 | 50,600 |
| 13/01/26 | 40.09 | 41.99 | 40.09 | 40.63 | 38,391 |
|
|
||||
|
|
||||
|
|